New review suggests balanced biocide use for sustainability and health benefits

FHS
August 9, 2024
11:22 pm

A recent review in the journal Sustainable Microbiology discusses how the use of biocides can promote well-being – but must only be used when there are clear benefits.

Early metformin therapy falls short in curbing gestational diabetes woes

In a significant randomized clinical trial, early metformin therapy was tested for its potential to lessen insulin dependence and enhance glycemic control in gestational diabetes-afflicted

October 4, 2023

Pharmalittle: We’re reading about fake studies, AbbVie investing in psychedelics, and more

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more

May 15, 2024

ESC 2024: Beta blocker treatment paradigm shifts for myocardial infarction – Pharmaceutical Technology

At the ESC Congress, Dr. Milton Packer highlighted recent research into beta blocker treatment for myocardial infarction. Credit: luchschenF via Shutterstock. A shift in the

September 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.